PRESS RELEASE published on 06/08/2026 at 21:00, 4 months 27 days ago Oxurion lance une stratégie de croissance axée sur le logiciel avec Exagis Oxurion annonce une stratégie de croissance logicielle centrée sur sa plateforme Exagis pour la recherche clinique, visant une évolution vers un écosystème logiciel complet Recherche Clinique Plateforme Logicielle Oxurion Exagis Croissance Logicielle
PRESS RELEASE published on 06/08/2026 at 21:00, 4 months 27 days ago Oxurion launches a software-driven growth strategy with Exagis Oxurion NV announces the software-driven growth strategy launch centered on Exagis, its proprietary clinical research platform. The platform evolves into a broad CDMS commercially serving clinical development market Oxurion NV Exagis Clinical Research Platform Software-driven Growth Strategy CDMS
PRESS RELEASE published on 06/08/2026 at 21:00, 4 months 27 days ago Oxurion lanceert een softwaregedreven groeistrategie met Exagis Oxurion NV kündigt die Einführung einer softwaregesteuerten Wachstumsstrategie für sein klinisches Forschungsplattform Exagis an. Die Plattform wird separat kommerzialisiert, um Softwareeinnahmen zu generieren Wachstumsstrategie Oxurion NV Klinische Forschung Exagis Softwaregesteuert
BRIEF published on 06/03/2026 at 18:05, 5 months 2 days ago Oxurion Approves Agenda at Annual Shareholders' Meeting Forward-looking Statements Shareholders' Meeting Oxurion NV Leuven Agenda Approval
BRIEF published on 06/03/2026 at 18:05, 5 months 2 days ago Oxurion Annonce les Résultats de son Assemblée Générale Annuelle Assemblée Générale Investissements Résultats Pharmaceutique Oxurion
BRIEF published on 06/03/2026 at 18:05, 5 months 2 days ago Oxurion Announces the Results of its Annual General Meeting Pharmaceutical Investments General Assembly Results Oxurion
BRIEF published on 06/03/2026 at 18:05, 5 months 2 days ago Oxurion approuve l'ordre du jour de son assemblée générale annuelle des actionnaires Déclarations Prospectives Assemblée Générale Des Actionnaires Oxurion NV Louvain Approbation De L'ordre Du Jour
PRESS RELEASE published on 06/03/2026 at 18:00, 5 months 2 days ago Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026 Oxurion NV houdt succesvolle jaarlijkse aandeelhoudersvergadering waar alle agenda-items zijn goedgekeurd. Meer informatie beschikbaar op de website. Toekomstgerichte verklaringen van kracht Oxurion NV Aandeelhoudersvergadering Europese Farmaceutische Onderaannemers Toekomstgerichte Verklaringen
PRESS RELEASE published on 06/03/2026 at 18:00, 5 months 2 days ago Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026 Oxurion NV (Euronext Brussels: OXUR) successfully held its annual shareholders' meeting in Leuven, with all agenda items approved. Find more about the biopharmaceutical company at oxurion.com Biopharmaceutical Euronext Brussels Annual Shareholders' Meeting Oxurion NV Leuven
BRIEF published on 06/02/2026 at 18:05, 5 months 3 days ago Oxurion élargit son offre en recherche clinique ciblant les GLP-1 et peptides Recherche Clinique GLP-1 Oxurion Peptides Biométrie
Published on 11/06/2026 at 00:53, 1 hour 5 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 13 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 3 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 2 hours 38 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 1 hour 53 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 3 hours 53 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 20 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 21 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 12 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 7 hours 36 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 7 hours 36 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
